Echinacea Reduces the Risk of Recurrent Respiratory Tract Infections and Complications: A Meta-Analysis of Randomized Controlled Trials

Advances in Therapy

Volumn 32, Issue 3, 2015, Pages 187-200

  Schapowal, Andreas ^a   Klein, Peter ^b   Johnston, Sebastian L ^c,d  

^a Allergy Clinic   (Switzerland)

^b Dsh Statistical Services GmbH   (Germany)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Complications; Echinacea; Meta analysis; Recurrences; Respiratory tract infections

Indexed keywords

PLANT EXTRACT;

ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; ECHINACEA; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MALE; MENTAL STRESS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTIONS;

ADOLESCENT; ADULT; CHILD; ECHINACEA; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; STRESS, PSYCHOLOGICAL;

EID: 84936928863     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-015-0194-4     Document Type: Review

References (39)

1. Johnston SL. Cromolyns: treatment for the common cold? Clin Exp Allergy. 1996;26:989–94.
2. Levandowski RA, Ou DW, Jackson GG. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis. 1986;153:743–8.
3. Aherne W, Bird T, Court SDM, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol. 1970;23:7–18.
4. Elkhatieb A, Hipskind G, Woerner D, Hayden FG. Middle ear abnormalities during natural rhinovirus colds in adults. J Infect Dis. 1993;168:618–21.
5. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J. 1997;16:43–7.
6. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008;82:2040–55.
7. Pene F, Merlat A, Vabret A, et al. Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis. 2003;37:929–32.
8. Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol. 2004;75:5–17.
9. Fox JP, Cooney MK, Hall CE. The Seattle virus watch. V. Epidemiologic observations of rhinovirus infections, 1965–1969, in families with young children. Am J Epidemiol. 1975;101:122–43.
10. Gertsch J, Schoop R, Kuenzle U, Suter A. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. FEBS Lett. 2004;577(3):563–9.
11. Ritchie MR, Gertsch J, Klein P, Schoop R. Effects of Echinaforce(R) treatment on ex vivo-stimulated blood cells. Phytomedicine. 2011;18:826–31.
12. Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J. 2009;6:197.
13. Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007;7:473–80.
14. Schoop R, Klein P, Suter A, Johnston SL. Echinacea in the prevention of induced rhinovirus colds: a meta-analysis. Clin Ther. 2006;28:174–83.
15. Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;2:CD000530.
16. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290:2824–30.
17. Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med. 1999;106:138–43.
18. Schmidt U, Albrecht M, Schenk N. Pflanzliches Immunstimulans senkt Häufigkeit grippaler Infekte. Natur- und Ganzheitsmedizin. 1990;3:277–81.
19. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med. 1998;7:541–5.
20. Cohen HA, Varsano I, Kahan E, Sarrell EM, Uziel Y. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med. 2004;158:217–21.
21. Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2012;2012:841315.
22. Moher D, Cook DJ, Jadad AR, et al. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess. 1999;3:1–98.
23. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analysis: the PRISMA statement. PLoS Med. 2009;6:e1000097.
25. Whitehead A. Meta-analysis of controlled clinical trials. Chichester: Wiley Ltd.; 2002. p. 352.
26. Hedges LV, Olkin I. Statistical methods for meta-analysis. London: Academic Press; 1985. p. 369.
27. Berg A, Northoff H, Konig D, et al. Influence of echinacin (ED31) treatment on the exercise-induced immune response in athletes. J Clin Res. 1998;1:367–80.
28. Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353:341–8.
29. Turner RB, Riker DK, Gangemi JD. Ineffectiveness of echinacea for prevention of experimental rhinovirus colds. Antimicrob Agents Chemother. 2000;44:1708–9.
30. Sperber SJ, Shah LP, Gilbert RD, Ritchey TW, Monto A. Echinacea purpurea for prevention of experimental rhinovirus colds. Clin Infect Dis. 2004;38:1367–71.
31. Schoeneberger C. The influence of the immuno stimulating effects of pressed juice from Echinacea purpurea on the course and severity of cold infections. Forum Immunologie. 1992;8:18–22.
32. Weber W, Taylor JA, Stoep AV, Weiss NS, Standish LJ, Calabrese C. Echinacea purpurea for prevention of upper respiratory tract infections in children. J Altern Complement Med. 2005;11:1021–6.
33. Hoheisel O, Sandberg M, Bertram S, Bulitta M, Schafer M. Echinaguard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur J Clin Res. 1997;9:261–8.
34. Heinen-Kammerer T, Holtmannspötter C, Schnabel S, Motzkat K, Kiencke P, Rychlik R. Nutzenbewertung der Therapie chronisch rezidivierender Atemwegsinfekte mit Echinacin. Gesundheitswesen. 2005;67:296–301.
35. Bauer R. In: Bauer R, Wagner H, editors. Echinacea: Handbuch für Ärzte, Apotheker und andere Naturwissenschaftler. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1990. p. 9–21.
36. Jackson GG, Dowling HF, Spiesman IG, Boand AV. Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. AMA Arch Intern Med. 1958;101:267–78.
37. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163:487–94.
38. European Scientific Cooperative on Phytotherapy (ESCOP). Echinacea purpurea herba/radix. In: ESCOP Monographs, 2nd edition, Suppl. New York, NY, USA: Thieme, 2009. pp. 91–109.
39. Barrett B, Brown R, Rakel D, et al. Placebo effects and the common cold: a randomized controlled trial. Ann Fam Med. 2011;9:312–22.